Opko Health (OPK) Capital Expenditures (2010 - 2026)

Opko Health (OPK) has 17 years of Capital Expenditures data on file, last reported at $3.0 million in Q2 2026.

• Quarterly Capital Expenditures fell 8.5% year-over-year to $3.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $10.6 million (down 71.81% YoY) and the FY2025 annual result came in at $12.3 million, down 50.91% from the prior year.
• Capital Expenditures advanced to $3.0 million in Q2 2026, from $1.8 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $19.6 million in Q3 2024 to a low of $1.8 million in Q1 2026.
• A 5-year average of $5.5 million and a median of $4.2 million in 2023 frame the typical range for Capital Expenditures.
• Annual changes were most pronounced in 2024 — Capital Expenditures surged 366.26% — and 2025, when it slumped 84.0%.
• Tracing OPK's Capital Expenditures over 5 years: stood at $6.3 million in 2022, then plunged by 52.3% to $3.0 million in 2023, then soared by 548.48% to $19.6 million in 2024, then plunged by 86.4% to $2.7 million in 2025, then gained by 12.68% to $3.0 million in 2026.
• The last three Capital Expenditures figures came in at $3.0 million (Q2 2026), $1.8 million (Q1 2026), and $2.7 million (Q4 2025), per Business Quant data.